Home -
Products -
Others -
Other Targets -
5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone
5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone
CAS No. 141846-47-1
5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone( —— )
Catalog No. M31798 CAS No. 141846-47-1
3'-Dimethylallylkievitone is a natural product for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 810 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone
-
NoteResearch use only, not for human use.
-
Brief Description3'-Dimethylallylkievitone is a natural product for research related to life sciences.
-
Description3'-Dimethylallylkievitone is a natural product for research related to life sciences.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number141846-47-1
-
Formula Weight424.5
-
Molecular FormulaC25H28O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Isoferulic acid
3-Hydroxy-4-methoxycinnamic Acid exhibits hypoglycemic properties.
-
Dehydrocurdione
Dehydrocurdione, a zedoary-derived sesquiterpene, induces heme oxygenase (HO)-1, an antioxidative enzyme, in RAW 264.7 macrophages. Dehydrocurdione interacts with Keap1, resulting in Nrf2 translocation followed by activation of the HO-1 E2 enhancer. Dehydrocurdione suppresses lipopolysaccharide-induced NO release, a marker of inflammation. Anti-inflammatory activity.
-
LY-3475070
LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
Cart
sales@molnova.com